• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期和晚期结直肠癌患者生存预测工具的开发与验证

Development and validation of survival prediction tools in early and late onset colorectal cancer patients.

作者信息

Li Wanling, Liu Jinshan, Lan Yuntong, Yu Dongling, Zhang Bingqiang

机构信息

Department of Gastroenterology, University-Town Hospital of Chongqing Medical University, Chongqing, 401331, China.

Department of Gastroenterology, Chongqing Hospital of Jiangsu Province Hospital, The People's Hospital of Qijiang District, Chongqing, 401420, China.

出版信息

Sci Rep. 2025 Apr 15;15(1):12864. doi: 10.1038/s41598-025-95385-0.

DOI:10.1038/s41598-025-95385-0
PMID:40229310
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11997042/
Abstract

This study aims to develop online calculators using machine learning models to predict survival probabilities for early- and late-onset colorectal cancer (EOCRC and LOCRC) over a 1- to 8-year period. We extracted data on 117,965 CRC patients from the published database spanning 2010 to 2021, divided into training and internal testing datasets. The data of 200 CRC patients from Chongqing Hospital of Jiangsu Province Hospital was used as the external testing dataset. We conducted univariate and multivariate regression analyses on the training dataset to identify key survival factors and develop predictive machine learning models. The models were evaluated using internal and external testing datasets based on AUC, accuracy, precision, recall, and F1 score. Web-based calculators were subsequently developed to predict survival curves for EOCRC and LOCRC patients under different treatment strategies. In the multivariate Cox regression analysis, 16 and 18 variables were independently significant survival factors for EOCRC and LOCRC, respectively. In the EOCRC group, the machine learning models achieved AUC values of 0.880 and 0.804 in the internal and external testing cohorts. For the LOCRC group, the machine learning models exhibited AUC values of 0.857 and 0.823 in the internal and external testing cohorts. The online calculators, powered by trained machine learning models, are accessible at https://eocrc-surv.streamlit.app/ and https://locrc-surv.streamlit.app/ . These tools estimate survival probabilities for EOCRC and LOCRC patients under various treatment strategies and display the corresponding survival curves post-treatment over the 1- to 8-year period. This study successfully developed online calculators using machine learning algorithms to predict 1- to 8-year survival probabilities for EOCRC and LOCRC patients under various treatment strategies.

摘要

本研究旨在使用机器学习模型开发在线计算器,以预测早发性和晚发性结直肠癌(EOCRC和LOCRC)在1至8年期间的生存概率。我们从2010年至2021年发布的数据库中提取了117,965例CRC患者的数据,分为训练数据集和内部测试数据集。来自江苏省医院重庆医院的200例CRC患者的数据用作外部测试数据集。我们对训练数据集进行了单变量和多变量回归分析,以确定关键生存因素并开发预测性机器学习模型。基于AUC、准确性、精确性、召回率和F1分数,使用内部和外部测试数据集对模型进行评估。随后开发了基于网络的计算器,以预测不同治疗策略下EOCRC和LOCRC患者的生存曲线。在多变量Cox回归分析中,16个和18个变量分别是EOCRC和LOCRC独立的显著生存因素。在EOCRC组中,机器学习模型在内部和外部测试队列中的AUC值分别为0.880和0.804。对于LOCRC组,机器学习模型在内部和外部测试队列中的AUC值分别为0.857和0.823。由经过训练的机器学习模型驱动的在线计算器可在https://eocrc-surv.streamlit.app/和https://locrc-surv.streamlit.app/上访问。这些工具可估计不同治疗策略下EOCRC和LOCRC患者的生存概率,并显示治疗后1至8年期间相应的生存曲线。本研究成功地使用机器学习算法开发了在线计算器,以预测不同治疗策略下EOCRC和LOCRC患者1至8年的生存概率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/11997042/7de4c16b4921/41598_2025_95385_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/11997042/443b645b40ad/41598_2025_95385_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/11997042/f88985f56e59/41598_2025_95385_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/11997042/3756dba855fa/41598_2025_95385_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/11997042/73d3738257d5/41598_2025_95385_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/11997042/ed0bf6fe413b/41598_2025_95385_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/11997042/fdfc4b237862/41598_2025_95385_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/11997042/d3ea80d8a5ba/41598_2025_95385_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/11997042/7de4c16b4921/41598_2025_95385_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/11997042/443b645b40ad/41598_2025_95385_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/11997042/f88985f56e59/41598_2025_95385_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/11997042/3756dba855fa/41598_2025_95385_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/11997042/73d3738257d5/41598_2025_95385_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/11997042/ed0bf6fe413b/41598_2025_95385_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/11997042/fdfc4b237862/41598_2025_95385_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/11997042/d3ea80d8a5ba/41598_2025_95385_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73f2/11997042/7de4c16b4921/41598_2025_95385_Fig8_HTML.jpg

相似文献

1
Development and validation of survival prediction tools in early and late onset colorectal cancer patients.早期和晚期结直肠癌患者生存预测工具的开发与验证
Sci Rep. 2025 Apr 15;15(1):12864. doi: 10.1038/s41598-025-95385-0.
2
Five-year overall survival of early- and late-onset colorectal cancer in Medellín, Colombia: a comparative study.哥伦比亚麦德林地区早发性和晚发性结直肠癌的 5 年总生存率:一项对比研究。
J Cancer Res Clin Oncol. 2024 Nov 9;150(11):490. doi: 10.1007/s00432-024-06007-7.
3
Trends and Symptoms Among Increasing Proportion of African Americans with Early-Onset Colorectal Cancer over a 60-Year Period.60年间早发性结直肠癌的非裔美国人比例上升过程中的趋势与症状
Dig Dis Sci. 2025 Jan;70(1):168-176. doi: 10.1007/s10620-024-08739-5. Epub 2024 Nov 25.
4
A decade-long study on pathological distinctions of resectable early versus late onset colorectal cancer and optimal screening age determination.一项长达十年的研究,旨在探讨可切除的早发性和晚发性结直肠癌的病理差异,以及最佳筛查年龄的确定。
Sci Rep. 2024 Nov 9;14(1):27335. doi: 10.1038/s41598-024-76951-4.
5
Survival outcome and prognostic factors for early-onset and late-onset metastatic colorectal cancer: a population based study from SEER database.早发性和晚发性转移性结直肠癌的生存结果和预后因素:来自 SEER 数据库的一项基于人群的研究。
Sci Rep. 2024 Feb 22;14(1):4377. doi: 10.1038/s41598-024-54972-3.
6
[Epidemiological characteristics of early-onset colorectal cancer: a prospective cohort study from a single center].早发性结直肠癌的流行病学特征:一项来自单一中心的前瞻性队列研究
Zhonghua Wei Chang Wai Ke Za Zhi. 2024 May 25;27(5):457-463. doi: 10.3760/cma.j.cn441530-20240222-00069.
7
Trends, clinicopathological features, surgical treatment patterns and prognoses of early-onset versus late-onset colorectal cancer: A retrospective cohort study on 34067 patients managed from 2000 to 2021 in a Chinese tertiary center.早发性与晚发性结直肠癌的趋势、临床病理特征、手术治疗模式和预后:一项回顾性队列研究,纳入了 2000 年至 2021 年在中国一家三级中心接受治疗的 34067 例患者。
Int J Surg. 2022 Aug;104:106780. doi: 10.1016/j.ijsu.2022.106780. Epub 2022 Jul 16.
8
Differences in characteristics and outcomes between early-onset colorectal cancer and late-onset colorectal cancers.早发性和晚发性结直肠癌的特征和结局差异。
Eur J Surg Oncol. 2024 Dec;50(12):108687. doi: 10.1016/j.ejso.2024.108687. Epub 2024 Sep 11.
9
Geographic Variation and Risk Factor Association of Early Versus Late Onset Colorectal Cancer.早发性与晚发性结直肠癌的地理差异及危险因素关联
Cancers (Basel). 2023 Feb 4;15(4):1006. doi: 10.3390/cancers15041006.
10
Comparative characteristics of early-onset vs. late-onset advanced colorectal cancer: a nationwide study in China.早发性与晚发性晚期结直肠癌的比较特征:中国的一项全国性研究。
BMC Cancer. 2024 Apr 20;24(1):503. doi: 10.1186/s12885-024-12278-7.

本文引用的文献

1
The survival prediction of advanced colorectal cancer received neoadjuvant therapy-a study of SEER database.接受新辅助治疗的晚期结直肠癌的生存预测——SEER 数据库研究。
World J Surg Oncol. 2024 Jul 1;22(1):175. doi: 10.1186/s12957-024-03458-7.
2
Construction and validation of a nomogram for predicting overall survival of patients with stage III/IV early-onset colorectal cancer.用于预测Ⅲ/Ⅳ期早发性结直肠癌患者总生存期的列线图的构建与验证
Front Oncol. 2024 Apr 10;14:1332499. doi: 10.3389/fonc.2024.1332499. eCollection 2024.
3
Machine learning for predicting survival of colorectal cancer patients.
机器学习预测结直肠癌患者的生存情况。
Sci Rep. 2023 Jun 1;13(1):8874. doi: 10.1038/s41598-023-35649-9.
4
The Rising Incidence of Early-Onset Colorectal Cancer.早发性结直肠癌发病率上升。
Dtsch Arztebl Int. 2023 Feb 3;120(Forthcoming):59-64. doi: 10.3238/arztebl.m2022.0368.
5
Smad7 Sustains Stat3 Expression and Signaling in Colon Cancer Cells.Smad7维持结肠癌细胞中Stat3的表达和信号传导。
Cancers (Basel). 2022 Oct 12;14(20):4993. doi: 10.3390/cancers14204993.
6
Transcriptome Analyses Identify Deregulated in Early Onset Colorectal Cancer.转录组分析鉴定出早发性结直肠癌中失调的 。
Biomolecules. 2022 Sep 2;12(9):1223. doi: 10.3390/biom12091223.
7
Colon and Rectal Cancer Management in Low-Resource Settings.资源匮乏地区的结肠癌和直肠癌管理
Clin Colon Rectal Surg. 2022 Sep 13;35(5):402-409. doi: 10.1055/s-0042-1746189. eCollection 2022 Sep.
8
Trends, clinicopathological features, surgical treatment patterns and prognoses of early-onset versus late-onset colorectal cancer: A retrospective cohort study on 34067 patients managed from 2000 to 2021 in a Chinese tertiary center.早发性与晚发性结直肠癌的趋势、临床病理特征、手术治疗模式和预后:一项回顾性队列研究,纳入了 2000 年至 2021 年在中国一家三级中心接受治疗的 34067 例患者。
Int J Surg. 2022 Aug;104:106780. doi: 10.1016/j.ijsu.2022.106780. Epub 2022 Jul 16.
9
Clinical management of metastatic colorectal cancer in the era of precision medicine.精准医学时代转移性结直肠癌的临床管理。
CA Cancer J Clin. 2022 Jul;72(4):372-401. doi: 10.3322/caac.21728. Epub 2022 Apr 26.
10
Early-onset colorectal cancer: why it should be high on our list of differentials.早发性结直肠癌:为何应将其作为鉴别诊断的重点。
ANZ J Surg. 2022 Jul;92(7-8):1638-1643. doi: 10.1111/ans.17698. Epub 2022 Apr 21.